NCT00255749已完成2 期
Assessment of Early and Standard Intervention With Procrit® (Epoetin Alfa) 120,000 Units Once Every Three Weeks (Q3W) in Patients With Cancer Receiving Chemotherapy
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 89
- 试验地点
- 2
- 主要终点
- Efficacy
研究概览
简要总结
RATIONALE: Epoetin alfa may cause the body to make more red blood cells. It is used to treat anemia caused by cancer and chemotherapy.
PURPOSE: This randomized phase II trial is studying how well epoetin alfa works in treating patients with anemia who are undergoing chemotherapy for cancer.
详细描述
OBJECTIVES:
Primary
- Determine the efficacy, in terms of maintenance of target hemoglobin and hematocrit levels, of interval dosing with epoetin alfa in patients with anemia undergoing chemotherapy for nonmyeloid cancer.
- Determine the safety of this drug in these patients.
Secondary
- Determine the quality of life of patients treated with this drug.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Efficacy
时间窗: 7 weeks
Safety
时间窗: 7 weeks
次要结局
- Quality of life(7 weeks)
研究者
研究点 (2)
Loading locations...
相似试验
终止
不适用
Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for CancerFatigueUnspecified Adult Solid Tumor, Protocol SpecificAnemiaNCT00258440OHSU Knight Cancer Institute7
已完成
3 期
Epoetin Alfa in Treating Anemia in Patients With Solid TumorsLeukemiaAnemiaLymphoproliferative DisorderMultiple Myeloma and Plasma Cell NeoplasmPrecancerous ConditionLymphomaUnspecified Adult Solid Tumor, Protocol SpecificNCT00058331Alliance for Clinical Trials in Oncology365
已完成
3 期
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving ChemotherapyChronic Myeloproliferative DisordersDrug/Agent Toxicity by Tissue/OrganBreast CancerAnemiaMultiple Myeloma and Plasma Cell NeoplasmPrecancerous ConditionSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol SpecificLung CancerLeukemiaLymphomaNCT00003600Alliance for Clinical Trials in Oncology344
已完成
不适用
Epoetin Alfa in Treating Anemia in Patients Undergoing Chemotherapy for Multiple MyelomaPlasma Cell NeoplasmMultiple MyelomaAnemiaNCT00400686The Cleveland Clinic31
已完成
4 期
Epoetin Alfa in Treating Chemotherapy-Related Anemia in Women With Stage I, Stage II, or Stage III Breast CancerFatigueBreast CancerAnemiaNCT00022386Jonsson Comprehensive Cancer Center